Clinical Trial: Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594431) titled 'Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.' on May 12.

Brief Summary: Unblinded, randomized study of 5-fraction LATTICE radiotherapy (20 Gy with an SIB to 66.7 Gy in 5 fractions) versus moderately dose-escalated palliative radiation (25 Gy in 5 fractions)

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Metastases Metastatic Cancer

Intervention: RADIATION: LATTICE Radiotherapy

5-fraction LATTICE radiotherapy delivered to 20 Gy with a simultaneous integrated boost (SIB) to 66.7 Gy.

RADIATION: Standard radiotherapy

Standard radiotherapy...